September 26, 2024
Age-related macular degeneration (AMD) is the leading cause of visual impairment in people over age 50 years. It affects the macula, the central part of the […]
September 23, 2024
A real-world retrospective study has shown that patients experiencing progressive daily vision loss from geographic atrophy (GA), a late form of nonexudative age-related macular degeneration, may […]
September 20, 2024
The European Medicines Agency (EMA) has announced its approval of two new biosimilar medications, Afqlir and Opuviz, to treat age-related macular degeneration (ARMD). The active ingredient […]
September 13, 2024
TOPLINE: Laughter exercise practiced four times a day was noninferior to 0.1% sodium hyaluronic acid in alleviating the symptoms of dry eye disease and improved tear […]
September 13, 2024
TOPLINE: A biosimilar demonstrated comparable efficacy and safety to aflibercept in treating diabetic macular edema. The vascular endothelial growth factor (VEGF) inhibitor was one of two […]
September 12, 2024
TOPLINE: Patients with ocular hypertension who develop primary open-angle glaucoma (POAG) without visual field loss did not experience a decreased vision-related quality of life compared with […]
September 10, 2024
An investigational gene therapy has shown promise for improving functional vision and restoring light detection in long-dormant rods and cones in the retina in adults and […]
September 10, 2024
(Reuters) -Viridian Therapeutics said on Tuesday its experimental treatment helped significantly reduce symptoms of thyroid eye disease (TED) in a late-stage study, setting the stage to […]
September 9, 2024
TOPLINE: Addressing vision impairments could help with dementia prevention, as vision impairment is linked to 19% of dementia cases in older adults. METHODOLOGY: Researchers conducted a […]